Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1,451

IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology

Phase I trial aims to build on response seen in proof-of-concept trial.

NEW YORK AND CAMBRIDGE, MASS. — JANUARY 27, 2022 — IAVI and biotechnology company Moderna announced today that first doses have been administered in a clinical trial of experimental HIV vaccine antigens at George Washington University (GWU) School of Medicine and Health Sciences in Washington, D.C. The Phase I trial, IAVI G002, is designed to test the hypothesis that sequential administration of priming and boosting HIV immunogens delivered by messenger RNA (mRNA) can induce specific classes of B-cell responses and guide their early maturation toward broadly neutralizing antibody (bnAb) development. The induction of bnAbs is widely considered to be a goal of HIV vaccination, and this is the first step in that process. The immunogens being tested in IAVI G002 were developed by scientific teams at IAVI and Scripps Research and will be delivered via Moderna’s mRNA technology.

IAVI and Moderna and do not necessarily reflect the views of USAID or the United States government.

Dr. Marilyn Roossinck, Ph.D. — Beneficial Viruses — Professor Emeritus, Penn State University

“Beneficial Viruses” For Human Health, Agriculture And Environmental Sustainability — Dr. Marilyn Roossinck, Ph.D., Professor Emeritus, Penn State

Dr. Marilyn Roossinck Ph.D. (https://plantpath.psu.edu/directory/mjr25) is Professor Emeritus of plant pathology, environmental microbiology and biology at Penn State University.

Dr. Roossinck is an expert on viruses, from their evolutionary pressures and mechanisms, to the ecology of viral diseases. She performed some of the first experimental evolution studies on plant viruses and pioneered the first virus discovery work in a terrestrial system, by deep sequencing wild plant samples. A specialty of hers is the symbiotic relationships between plants and so-called “beneficial viruses.”

Dr. Roossinck completed her undergraduate work at the University of Colorado, Boulder, receiving a biology degree in 1982. Four years later, she earned her doctorate in microbiology and immunology from the University of Colorado School of Medicine.

Dr. Roossinck joined Penn State as professor of plant pathology and environmental microbiology and of biology in 2011, holding appointments in the College of Agricultural Sciences and the Eberly College of Science. She taught courses in virus ecology for several years at Penn State, and also has published both a popular press book about viruses entitled “Virus: An Illustrated Guide to 101 Incredible Microbes” as well as the academic text “Plant Virus Evolution”.

Continue reading “Dr. Marilyn Roossinck, Ph.D. — Beneficial Viruses — Professor Emeritus, Penn State University” | >

Dr Katcher’s E5 Experiment

Another E5 update. At the moment there is a great difference between the control and treated rats. The treated rats are nearing their expected lifespan. And it looks like E5 human trials are trying to be set up.

In this video we report on the Feb 2022 update from Dr. Katcher’s experiment with E5, where he is testing to see how long the rats will stay alive if they are given an E5 injection every 90 days.

********************************************
Links for this video.
Sign up for the newsletter from NTZ Publishing here:
https://www.ntzplural.com/newsletter.
Reversing age: dual species measurement of epigenetic age with a single clock.
https://www.biorxiv.org/content/10.1101/2020.05.07.082917v1.full.

Our discussion of original paper.
https://youtu.be/DokfEzQt_wk.
Playlist for Dr. Katcher August 2021 Interview Series.

Playlist 1 for Dr. Katcher.
https://www.youtube.com/playlist?list=PLkfzM7KJv6vaIQZ_n3WS6FHTpBtfS2lzw.

********************************************

Continue reading “Dr Katcher’s E5 Experiment” | >

Motor Trend reimagines the ‘Apple Car,’ sees autonomous rideshare in Apple’s future

American auto magazine Motor Trend is back to rehash its initial predictions for Apple’s yet unannounced “Apple Car”, this time updating it for the “inevitable” autonomous future.

The new report is, once again, a think piece that collates a collection of rumors into Motor Trend’s best guess at what Apple might have in the works.

It doesn’t take long for the publication to reference its first stab at imagining the “Apple Car,” one which wound up being ridiculed for being too “podlike.” Yet, as Motor Trend points out, podlike cars are being developed all over.

Scientists use ‘sticky’ DNA to build organized structures of gel blocks

Researchers from the Okinawa Institute of Science and Technology Graduate University (OIST) have used microscopic strands of DNA to guide the assembly of gel blocks that are visible to the naked eye.

The blocks, which measure up to 2mm in length and contain DNA on their surface, self-assembled in around 10–15 minutes when mixed in a solution, the scientists reported today in the Journal of the American Chemical Society.

“These hydrogel blocks are, we believe, the largest objects so far that have been programmed by DNA to form organized structures,” said Dr. Vyankat Sontakke, first author of the study and a postdoctoral researcher in the OIST Nucleic Acid Chemistry and Engineering Unit.

Retracted coronavirus (COVID-19) papers

Omuterema AkhahendaAdmin.

🤔 if it is Optimus, can I buy it with Amazon Prime.

Wojtek TekOmuterema Akhahenda free delivery.

Alan LightAdmin.

More than just free delivery: self-delivery.

We should really come up with a new term for an autonomous robot that delivers itself this way. Probably some combination of the terms “auto” (for “self”) and “bot”.… See more.

Ron FriedmanJust when I thought I have enough Tesla stocks, it looks like I’ll buy more.

Continue reading “Retracted coronavirus (COVID-19) papers” | >

A small island nation has cooked up not 1, not 2 but 5 COVID vaccines. It’s Cuba!

Kamil MuzykaYes you are!

Nicholas MacDonald “Newton. Pfft.”

Omuterema Akhahenda shared a link.

In the early days of the COVID pandemic, Cuba decided it was going to make its own vaccine – even though vaccine development historically takes years, even decades, to bear fruit.

Why did the Communist island nation decide to go it alone?

It didn’t want to rely on the whims of foreign governments or international pharmaceutical companies to immunize its people. Cuba didn’t even sign up for the COVAX program, backed by the World Health Organization, that was promising to pur… See more.

Continue reading “A small island nation has cooked up not 1, not 2 but 5 COVID vaccines. It’s Cuba!” | >

Ivermectin shows ‘antiviral effect’ against COVID, Japanese company says

Info from Japan.

TOKYO, Jan 31 (Reuters) — Japanese trading and pharmaceuticals company Kowa Co Ltd (7807.T) on Monday said that anti-parasite drug ivermectin showed an “antiviral effect” against Omicron and other coronavirus variants in joint non-clinical research.

The company, which has been working with Tokyo’s Kitasato University on testing the drug as a potential treatment for COVID-19, did not provide further details. The original Reuters story misstated that ivermectin was “effective” against Omicron in Phase III clinical trials, which are conducted in humans.

Clinical trials are ongoing, but promotion of ivermectin as a COVID-19 treatment has generated controversy.